GSA Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History

GSA Capital Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$367K	Buy
2022 Q2	–	Sell
2022 Q1	$371K	Buy
2021 Q4	–	Sell
2021 Q3	$296K	Buy
2020 Q1	–	Sell
2019 Q4	$1.2M	Buy
2018 Q2	–	Sell
2018 Q1	$861K	Sell
2017 Q4	$1.89M	Buy